Evidence map›Paper›PMID 42870876›Full record

ArticleFrontiers in neurology2026

Apathy-depression overlap: unmasking hidden disability profiles in multiple sclerosis.

Serena Oliveri, Francesca Massaro, Clara Tambussi, Kyrie Piscopo, Matteo Guidetti, Tiziana Zaccone, Alessandra Mingione, Corinne Monzani, Sara Marceglia, Elena Vegni and 2 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Serena OliveriAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences (DISS), University of Milan, Milan, Italy.
Francesca MassaroAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences (DISS), University of Milan, Milan, Italy.
Clara TambussiAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences (DISS), University of Milan, Milan, Italy.
Kyrie PiscopoUnit of Clinical Psychology, Department of Mental Health and Dependencies, Santi Paolo and Carlo Hospitals, Milan, Italy.
Matteo GuidettiAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences (DISS), University of Milan, Milan, Italy.
Tiziana ZacconeAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences (DISS), University of Milan, Milan, Italy.
Alessandra MingioneAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences (DISS), University of Milan, Milan, Italy.
Corinne MonzaniAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences (DISS), University of Milan, Milan, Italy.
Sara MarcegliaAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences (DISS), University of Milan, Milan, Italy.
Elena VegniUnit of Clinical Psychology, Department of Mental Health and Dependencies, Santi Paolo and Carlo Hospitals, Milan, Italy.
Alberto PrioriAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences (DISS), University of Milan, Milan, Italy.
Filippo Martinelli BoneschiAldo Ravelli Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences (DISS), University of Milan, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple sclerosis (MS), the leading cause of non-traumatic neurological disability in young adults, features heterogeneous motor and non-motor symptoms including fatigue, apathy and depression. Although fatigue and depression are well-studied in MS disability progression, to date, the independent and combined contributions of apathy, fatigue and depression to neurological disability remain unexplored. Objective: This cross-sectional study assessed apathy, depression, and fatigue prevalence in 85 Italian MS patients, their associations with Expanded Disability Status Scale (EDSS) scores, and the relationship between psychological symptom profiles (apathy and/or depression) and disability. Non-parametric analyses and exploratory linear regression models were used. Results: In our sample of MS patients, the prevalence of apathy, depression and fatigue were 37.6%, 29.3%, and 51.8% respectively. Apathy (r = 0.30, Discussion: Co-occurring apathy and depression may identify an MS subgroup with greater neurological disability at the time of assessment emphasizing the potential value of systematic screening of motivational and affective disturbances in MS by all clinicians, particularly when they co-occur. Our results foster longitudinal studies that might determine whether these psychological profiles may predict future disability progression and whether their identification may inform integrated interventions aimed at improving clinical outcomes.

Indexed as

ApathyDepressionFatigueMultiple SclerosisAdultCross-Sectional StudiesDisability EvaluationFemaleHumansMaleMiddle AgedPrevalenceapathydepressiondisabilityfatiguemultiple sclerosispsychological profile

Identifiers

PMID42870876
PMCPMC13657959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.